U.S., Dec. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07291895) titled 'High Dose Radiotherapy for Palliation (Hi-D)' on Nov. 24.
Brief Summary: The goal of this clinical trial is to evaluate the feasibility of single-blind randomization between two palliative regimens - standard 24 Gray in 3 fractions vs a high-dose (Hi-D) 27 Gray in 3 fractions with dose escalation within the tumor in participants with bulky metastatic cancer.
The main question
Study Start Date: Jan. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Metastases
Palliative Radiotherapy
Intervention:
RADIATION: Palliative Radiotherapy
standard dose RT
RADIATION: Palliative Radiotherapy
high-dose RT
Recruitment Status: NOT_YET_REC...